Title:
Fellowship - PA: Takeda Canada and CIHR Institute of Genetics Rare Diseases
Agreement Value:
$107,500.00
Agreement Date:
Jul 1, 2023 - Jun 30, 2026
Description:
• CIHR – Institute of Genetics and Takeda Canada have a strategic interest in advancing research in Rare Diseases in Canada by equipping research trainees so that they emerge from their training as scientific, professional, or organizational leaders within and beyond the health research enterprise.
• This specific opportunity seeks to support postdoctoral fellows focused on one or more of the listed research areas below.
Organization:
Canadian Institutes of Health Research
Expected Results:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.
Location:
Montréal, Quebec, CA H3T 1C5
Reference Number:
236-2023-2024-Q2-00328
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Additional Information:
Amendment 1: Agreement Value in CAD. Amendment 2: Agreement Value in CAD.
Amendment Date
Jun 30, 2024
Recipient's Legal Name:
Dupas, Thomas C
Research Organization:
Centre hospitalier universitaire Sainte-Justine (Montréal, Québec)
Program:
Research in Priority Areas
Program Purpose:
This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.